Blue Water Acquisition Corp.
Completed
Follow
Detailed Information
Information on this SPAC.
- Sponsors
- IPO Size
- $50M
- Underwriters
- Focus
- Healthcare, Life Sciences, Pharmaceuticals
- SEC Filings
- 1817944
- Public Embarc Page
- https://embarc.com/capital/spac/1817944/BLUW/blue-water-acquisition
- IPO Ticker
- BLUW
SPAC Leadership
Information on the SPAC leadership.
- Chairman and Chief Executive OfficerJoseph Hernandez
- DirectorKimberly Murphy
- DirectorJames Sapirstein
- DirectorMichael Lerner
- DirectorYvonne McBurney
- Chief Financial OfficerJon Garfield
Target Information
Information on the SPAC target for merger.
- Company
- Clarus Therapeutics
- Presentation
- Investor Presentation (SEC) on 2021-05-19
- Description
- Clarus is "a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women."